Related Experiment Videos
[Allergic myocarditis in clozapine treatment]
1Patologisk institut, Arhus Amtssygehus.
Ugeskrift for Laeger
|July 11, 1994
Summary
Clozapine, an antipsychotic, can cause myocarditis leading to death. This case highlights the cardiac risks associated with clozapine treatment in patients with pre-existing heart conditions.
Area of Science:
- Cardiology
- Psychiatry
- Toxicology
Background:
- Clozapine is a potent antipsychotic reserved for treatment-resistant cases.
- Patients with cardiovascular disease are often excluded from clozapine trials.
- Standard antipsychotics carry a lower risk profile for cardiac events.
Observation:
- A 45-year-old male with ischemic heart disease was initiated on clozapine.
- The patient developed cardiogenic shock 11 days after starting clozapine.
- Autopsy revealed coronary atherosclerosis and myocardial interstitial fibrosis.
Findings:
- A significant infiltration of eosinophilic granulocytes was observed in the myocardium.
- Myocarditis was identified as the probable cause of death.
- Clozapine treatment was strongly implicated in the fatal cardiac event.
Implications:
- This case underscores the potential cardiotoxicity of clozapine, particularly in vulnerable patients.
- Careful cardiac monitoring is crucial for patients with pre-existing ischemic heart disease starting clozapine.
- Risk-benefit assessment for clozapine should rigorously consider cardiac comorbidities.